516 related articles for article (PubMed ID: 9536388)
41. Evolution of primary Raynaud's phenomenon (Raynaud's disease) to connective tissue disease.
Gerbracht DD; Steen VD; Ziegler GL; Medsger TA; Rodnan GP
Arthritis Rheum; 1985 Jan; 28(1):87-92. PubMed ID: 3871330
[TBL] [Abstract][Full Text] [Related]
42. Systemic lupus erythematosus and Raynaud's phenomenon.
Heimovski FE; Simioni JA; Skare TL
An Bras Dermatol; 2015; 90(6):837-40. PubMed ID: 26734864
[TBL] [Abstract][Full Text] [Related]
43. Differences in red cell behaviour between patients with Raynaud's phenomenon and systemic sclerosis and patients with Raynaud's disease.
Rustin MH; Kovacs IB; Sowemimo-Coker SO; Maddison PJ; Kirby JD
Br J Dermatol; 1985 Sep; 113(3):265-72. PubMed ID: 3877518
[TBL] [Abstract][Full Text] [Related]
44. Serotonin and Raynaud's phenomenon.
Seibold JR
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S95-8. PubMed ID: 2412070
[TBL] [Abstract][Full Text] [Related]
45. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
Stoyneva Z
Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
[TBL] [Abstract][Full Text] [Related]
46. Comparative assessment of the effects of vasodilators on peripheral vascular reactivity in patients with systemic scleroderma and Raynaud's phenomenon: color Doppler flow imaging study.
Aikimbaev KS; Oğuz M; Ozbek S; Demirtaş M; Birand A; Batyraliev T
Angiology; 1996 May; 47(5):475-80. PubMed ID: 8644944
[TBL] [Abstract][Full Text] [Related]
47. The effect of sympathetic blockade and cooling in Raynaud's phenomenon.
Engelhart M
Clin Physiol; 1990 Mar; 10(2):131-6. PubMed ID: 2318024
[TBL] [Abstract][Full Text] [Related]
48. Plethysmographic cold test for diagnosis and evaluation of the severity of Raynaud's phenomenon. Validation of the method by factorial analysis of correspondences in 541 patients.
Pistorius MA; Planchon B; de Faucal P
Int Angiol; 1994 Mar; 13(1):10-4. PubMed ID: 8077791
[TBL] [Abstract][Full Text] [Related]
49. Local cold exposure test with a new arterial photoplethysmographic sensor in healthy controls and patients with secondary Raynaud's phenomenon.
Hahn M; Hahn C; Jünger M; Steins A; Zuder D; Klyscz T; Büchtemann A; Rassner G; Blazek V
Microvasc Res; 1999 Mar; 57(2):187-98. PubMed ID: 10049666
[TBL] [Abstract][Full Text] [Related]
50. Cutaneous microcirculation in systemic sclerosis and response to intra-arterial reserpine.
Nilsen KH; Jayson MI
Br Med J; 1980 Jun; 280(6229):1408-11. PubMed ID: 7427134
[TBL] [Abstract][Full Text] [Related]
51. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
Vayssairat M; Blaison N; Baudot N; Evenou P; Gilard M; Mathieu JF
J Mal Vasc; 1989; 14(4):299-302. PubMed ID: 2584886
[TBL] [Abstract][Full Text] [Related]
52. Effect of cold stress on coronary sinus blood flow in patients with scleroderma.
Colfer HT; Das SK; Dabich L; Randall OS; Pitt B
J Assoc Acad Minor Phys; 1993; 4(2):62-5. PubMed ID: 8490289
[TBL] [Abstract][Full Text] [Related]
53. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis.
Sunderkötter C; Riemekasten G
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii33-5. PubMed ID: 16987831
[TBL] [Abstract][Full Text] [Related]
54. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
Kahan A; Weber S; Amor B; Menkes CJ; Hodara M; Degeorges M
Int Angiol; 1985; 4(2):221-3. PubMed ID: 3831143
[TBL] [Abstract][Full Text] [Related]
55. Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis.
Ellis WW; Baer AN; Robertson RM; Pincus T; Kronenberg MW
Am J Med; 1986 Mar; 80(3):385-92. PubMed ID: 3953616
[TBL] [Abstract][Full Text] [Related]
56. [Comparison of humeral blood flow during rewarming and recooling of the hand in normal subjects or presenting Raynaud's phenomenon].
Savin E; Kedra AW; Oliva I; Bonnin P; Martineaud JP
J Mal Vasc; 1989; 14(4):312-9. PubMed ID: 2685159
[TBL] [Abstract][Full Text] [Related]
57. Blood flow changes with naftidrofuryl in systemic sclerosis and Raynaud's phenomenon.
Gaylarde PM; Tan OT; Sarkany I
Br J Dermatol; 1980 Jan; 102(1):7-10. PubMed ID: 7378283
[TBL] [Abstract][Full Text] [Related]
58. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
59. [The natural course of Raynaud's phenomenon].
Clavijo F; Krahenbuhl B
Schweiz Med Wochenschr; 1981 Dec; 111(51):2023-7. PubMed ID: 7313657
[TBL] [Abstract][Full Text] [Related]
60. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension.
Wigley FM
Curr Opin Rheumatol; 1996 Nov; 8(6):561-8. PubMed ID: 9018460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
